Prof. Dr. Gül Başaran

Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology, 2009

DOI 10.1200/jco.2009.27.15_suppl.e19055 Frei zugänglicher VolltextQuelle: OpenAlex

Pulmonary toxicity in patients receiving docetaxel chemotherapy

Journal of Clinical Oncology, 2009

DOI 10.1200/jco.2009.27.15_suppl.e13532 Frei zugänglicher VolltextQuelle: OpenAlex

Immunohistochemically Defined T1N0 Breast Cancer Subgroups Have Different Clinical Outcomes. A Retrospective Turkish Oncology Group Study.

Cancer Research, 2009

DOI 10.1158/0008-5472.sabcs-09-3167 Frei zugänglicher VolltextQuelle: OpenAlex

The outcome of patients with triple negative breast cancer: Evidence for a favorable ethnic subgroup? The Turkish Oncology Group experience

Journal of Clinical Oncology, 2009

DOI 10.1200/jco.2009.27.15_suppl.e22158 Quelle: ORCID

Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer

European Journal of Cancer Care, 2009

DOI 10.1111/j.1365-2354.2008.00973.x PMID 19267736 48 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Pulmonary toxicity in patients receiving docetaxel chemotherapy

Medical Oncology, 2009

DOI 10.1007/s12032-009-9391-9 PMID 20035385 9 Zitationen (OpenAlex) Quelle: OpenAlex

The association between individual attachment patterns, the perceived social support, and the psychological well‐being of Turkish informal caregivers

Psycho-Oncology, 2009

DOI 10.1002/pon.1441 PMID 19140124 68 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients: Single institution experience

Journal of Clinical Oncology, 2008

DOI 10.1200/jco.2008.26.15_suppl.15103 Quelle: OpenAlex

Clinical outcome of triple-negative (TN) breast cancer (BC)

Journal of Clinical Oncology, 2008

DOI 10.1200/jco.2008.26.15_suppl.11526 Quelle: OpenAlex

Impact of body mass index on cancer development.

PubMed, 2008

PMID 18404787 12 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Meme Kanserinde Adjuvan Sistemik Tedavi İlkeleri

Turkiye Klinikleri Medical Oncology - Special Topics, 2008

Quelle: OpenAlex

Outcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital

Journal of Clinical Oncology, 2007

DOI 10.1200/jco.2007.25.18_suppl.14588 Quelle: OpenAlex

P2-323: Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

Journal of Thoracic Oncology, 2007

DOI 10.1097/01.jto.0000284031.87598.62 Frei zugänglicher VolltextQuelle: OpenAlex

Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.

PubMed, 2007

PMID 17600873 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Vascular Endothelial Growth Factor, Hypoxia-Inducible Factor 1 Alpha and CD34 Expressions in Early-Stage Gastric Tumors: Relationship with Pathological Factors and Prognostic Impact on Survival

Oncology, 2007

DOI 10.1159/000111118 PMID 18025805 40 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

The role of adjuvant chemoradiotherapy (CRT) in Turkish patients with gastric carcinoma

Journal of Clinical Oncology, 2007

DOI 10.1200/jco.2007.25.18_suppl.15159 Frei zugänglicher VolltextQuelle: OpenAlex

Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial

The Breast, 2007

DOI 10.1016/j.breast.2007.09.002 PMID 17976988 49 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Epithelioid hemangioendothelioma with multiple organ involvement

Apmis, 2007

DOI 10.1111/j.1600-0463.2007.apm_727.x PMID 17614859 28 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Outcome of rectal carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital

Journal of Clinical Oncology, 2006

DOI 10.1200/jco.2006.24.18_suppl.13584 Quelle: OpenAlex

Outcome of adjuvant treatment in turkish breast cancer (BC) patients (PTS): Single institution experience

Kocaeli Üniversitesi - AVESİS, 2006

Quelle: OpenAlex

Outcome of metastatic colorectal cancer patients receiving palliative chemotherapy in Marmara University Hospital

Kocaeli Üniversitesi - AVESİS, 2006

Quelle: OpenAlex

Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

Kocaeli Üniversitesi - AVESİS, 2006

Quelle: OpenAlex

HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples.

Journal of experimental & clinical cancer research : CR, 2006

PMID 17310842 74 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Trastuzumab beyond progression in metastatic breast cancer

Trakya University's Institutional Open Access System (Trakya University), 2006

Frei zugänglicher VolltextQuelle: OpenAlex

VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival

Journal of Clinical Oncology, 2005

DOI 10.1200/jco.2005.23.16_suppl.4040 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Outcome of adjuvant treatment in elderly Turkish breast cancer patients

Journal of Clinical Oncology, 2005

DOI 10.1200/jco.2005.23.16_suppl.896 Frei zugänglicher VolltextQuelle: OpenAlex

The prognostic impact of body mass index (BMI) in early breast cancer (BC) patients (pts)

Journal of Clinical Oncology, 2005

DOI 10.1200/jco.2005.23.16_suppl.882 Quelle: OpenAlex

Chemoradiotherapy for Localized Non-Hodgkin's Lymphoma: Lessons From Old Studies

Journal of Clinical Oncology, 2005

DOI 10.1200/jco.2005.05.631 PMID 15860887 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

P-502 Outcome of patients with stage III and IV non-small cell lungcancer in Marmara University Hospital, Istanbul, Turkey

Lung Cancer, 2005

DOI 10.1016/s0169-5002(05)80995-x Quelle: OpenAlex

Ewing’s Sarcoma of the Rectum: Are Four Cycles of Chemotherapy Enough?

Journal of Clinical Oncology, 2005

DOI 10.1200/jco.2005.01.4928 PMID 16110043 Frei zugänglicher VolltextQuelle: OpenAlex

Does the incidence of anal canal cancers differ in Moslem societies?

International Journal of Colorectal Disease, 2004

DOI 10.1007/s00384-004-0614-4 PMID 15293063 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Human papilloma virus: Is it a new etiological factor in breast cancer?

Journal of Clinical Oncology, 2004

DOI 10.1200/jco.2004.22.14_suppl.9635 Frei zugänglicher VolltextQuelle: OpenAlex

Is the incidence of anal canal cancers different in Moslem societies?

Journal of Clinical Oncology, 2004

DOI 10.1200/jco.2004.22.14_suppl.4233 Frei zugänglicher VolltextQuelle: OpenAlex

FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens

Journal of Clinical Oncology, 2004

DOI 10.1200/jco.2004.22.14_suppl.3729 Frei zugänglicher VolltextQuelle: OpenAlex

Evre I (T1N0M0) meme kanseri: patolojik özellikler ve klinik sonuçlar.

2004

Quelle: OpenAlex

D-dimer – can it be a marker for malignant gastric lesions?

Acta Oncologica, 2004

DOI 10.1080/02841860410002743 PMID 15764225 8 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Attitude Toward Genetic Testing for Cancer Risk in Istanbul

Genetic Testing, 2004

DOI 10.1089/1090657041797239 PMID 15345115 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic value of thymidylate synthase and cox-2 expression in colorectal cancer patients' tumors

Journal of Clinical Oncology, 2004

DOI 10.1200/jco.2004.22.14_suppl.3731 Frei zugänglicher VolltextQuelle: OpenAlex

Clinical outcome of breast cancer (BC) patients (pts) with PT1N0M0 disease

Dspace Repository (Marmara Üniversitesi), 2004

Frei zugänglicher VolltextQuelle: OpenAlex